Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

DSIJ Intelligence Article rating: 3.4

The market opened in green on May 25, 2021, overall volumes in futures & options currently stand at 3,75,71,849 contracts with a turnover of Rs. 35,28,909.40 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

DSIJ Intelligence Article rating: 3.5

The market opened in green on May 25, 2021, overall volumes in futures & options currently stand at 3,75,71,849 contracts with a turnover of Rs. 35,28,909.40 crore.

Top performing penny stocks gained up to 468 per cent on YTD basis
Top performing penny stocks gained up to 468 per cent on YTD basis

Top performing penny stocks gained up to 468 per cent on YTD basis

Few of the penny stocks have turned out to be multibagger stocks like Jainco Projects ( India) Ltd gaining as much as 468 per cent.

DSIJ Intelligence Article rating: 3.4

There are stocks like Trijal Industries which doubled in May itself , gaining 108 per cent followed by TechIndia Nirma from infrastructure sector that gained more than 102 per cent since the beginning of this month.

Keep your eyes glued on these nine stocks today!
Keep your eyes glued on these nine stocks today!

Keep your eyes glued on these nine stocks today!

DSIJ Intelligence-3 Article rating: 3.3

EPL: The company informed that it has been selected as a partner by one of the world’s leading FMCG companies, GSK Consumer Healthcare (GSKCH), for achieving 100 per cent sustainability in the oral care segment.

Natco Pharma climbs 10 per cent on DCGI approval to begin production of 'Black Fungus' drug
Natco Pharma climbs 10 per cent on DCGI approval to begin production of 'Black Fungus' drug

Natco Pharma climbs 10 per cent on DCGI approval to begin production of 'Black Fungus' drug

DSIJ Intelligence Article rating: 4.3

The shares of Natco Pharma climbed over 10 per cent intraday on May 24, 2021, following the Drug Controller General of India (DCGI) approval to begin production of antifungal drug Amphotericin B liposomal injection, which is believed to be critical in the treatment of Mucormycosis, also called 'Black Fungus'. 

RSS
First24902491249224932495249724982499Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR